Literature DB >> 25093092

Prognostic factors in patients with recurrence after complete resection of esophageal squamous cell carcinoma.

Xiao-Dong Su1, Dong-Kun Zhang1, Xu Zhang1, Peng Lin1, Hao Long1, Tie-Hua Rong1.   

Abstract

BACKGROUND: Recurrence following complete resection of esophageal squamous cell carcinoma (SCC) still remains common. The aim of this study was to investigate the prognostic factors in patients with recurrence after complete resection of esophageal SCC.
METHODS: The medical records of 190 patients with recurrent disease after complete resection of esophageal SCC were retrospectively reviewed. Recurrence pattern was classified as loco-regional recurrence and distant metastases. The Kaplan-Meier method was used for the survival analysis. Cox proportional hazards model was used for multivariate analysis.
RESULTS: Mediastinal nodal clearance area was the most common sites of loco-regional recurrence, whereas lung, liver and bone were the most common sites for distant metastases. The median survival after recurrence was 8 months. The 1, 3, 5-year post-recurrence survival rates were 45.9%, 10.6% and 6.4%, respectively. The overall 1, 3, 5-year survival rates were 76.6%, 27.3% and 12.3%, respectively. The independent prognostic factors included time of recurrence (≥12 months vs. <12 months, HR: 3.228, 95% CI: 2.233-4.668), pattern of recurrence (local-regional recurrence vs. distant metastases, HR: 1.690, 95% CI: 1.170-2.439), and treatment of recurrence [no treatment vs. treatment (radiotherapy or surgery or chemotherapy), HR: 0.642, 95% CI: 0.458-0.899].
CONCLUSIONS: Our retrospective study showed that time of recurrence, pattern of recurrence and treatment of recurrence were independent prognostic factors in patients with recurrence after complete resection of esophageal SCC.

Entities:  

Keywords:  Esophageal carcinoma; esophagectomy; prognostic factor; recurrence

Year:  2014        PMID: 25093092      PMCID: PMC4120168          DOI: 10.3978/j.issn.2072-1439.2014.07.14

Source DB:  PubMed          Journal:  J Thorac Dis        ISSN: 2072-1439            Impact factor:   2.895


  25 in total

1.  Prognostic factors and patterns of recurrence in esophageal cancer assert arguments for extended two-field transthoracic esophagectomy.

Authors:  Justin K Smit; Bareld B Pultrum; Hendrik M van Dullemen; Gooitzen M Van Dam; Henk Groen; John T M Plukker
Journal:  Am J Surg       Date:  2010-04-20       Impact factor: 2.565

2.  Risk factors that influence early death due to cancer recurrence after extended radical esophagectomy with three-field lymph node dissection.

Authors:  Shin-Ichi Kosugi; Tatsuo Kanda; Kazuhito Yajima; Takashi Ishikawa; Katsuyoshi Hatakeyama
Journal:  Ann Surg Oncol       Date:  2011-04-16       Impact factor: 5.344

3.  A retrospective evaluation of radiotherapy for the treatment of local esophageal squamous cell carcinoma recurrence after initial complete surgical resection.

Authors:  Yu-liang Zhu; Qun Li; Jian-ming Gao; Ji-shi Li; Zhen-yu He; Jun-jie Xu; Xiao-jun Lu; Yu-meng Liu
Journal:  J Investig Med       Date:  2013-01       Impact factor: 2.895

4.  Localization of initial lymph node metastasis from carcinoma of the thoracic esophagus.

Authors:  T Matsubara; M Ueda; S Kaisaki; J Kuroda; C Uchida; N Kokudo; T Takahashi; T Nakajima; A Yanagisawa
Journal:  Cancer       Date:  2000-11-01       Impact factor: 6.860

5.  Therapeutic strategy for the treatment of postoperative recurrence of esophageal squamous cell carcinoma: clinical efficacy of radiotherapy.

Authors:  K Maruyama; S Motoyama; A Anbai; S Usami; Y Sato; K Shibuya; K Yoshino; T Nakatsu; Y Minamiya; J-I Ogawa
Journal:  Dis Esophagus       Date:  2010-10-13       Impact factor: 3.429

6.  Micrometastases in esophagogastric cancer: high detection rate in resected rib segments.

Authors:  G C O'sullivan; D Sheehan; A Clarke; R Stuart; J Kelly; M D Kiely; T Walsh; J K Collins; F Shanahan
Journal:  Gastroenterology       Date:  1999-03       Impact factor: 22.682

7.  Three-field lymphadenectomy for carcinoma of the esophagus and gastroesophageal junction in 174 R0 resections: impact on staging, disease-free survival, and outcome: a plea for adaptation of TNM classification in upper-half esophageal carcinoma.

Authors:  T Lerut; P Nafteux; J Moons; W Coosemans; G Decker; P De Leyn; D Van Raemdonck; N Ectors
Journal:  Ann Surg       Date:  2004-12       Impact factor: 12.969

Review 8.  Extended esophagectomy with 3-field lymph node dissection for esophageal cancer.

Authors:  Mitsuo Tachibana; Shoichi Kinugasa; Hiroshi Yoshimura; Dipok Kumar Dhar; Naofumi Nagasue
Journal:  Arch Surg       Date:  2003-12

9.  Treatment response and prognosis of patients after recurrence of esophageal cancer.

Authors:  Hideaki Shimada; Hiroyuki Kitabayashi; Yoshihiro Nabeya; Shin-ichi Okazumi; Hisahiro Matsubara; Yutaka Funami; Yukimasa Miyazawa; Tooru Shiratori; Takashi Uno; Hisao Itoh; Takenori Ochiai
Journal:  Surgery       Date:  2003-01       Impact factor: 3.982

10.  Salvage concurrent radio-chemotherapy for post-operative local recurrence of squamous-cell esophageal cancer.

Authors:  Jian Zhang; Feng Peng; Na Li; Yongmei Liu; Yong Xu; Lin Zhou; Jin Wang; Jiang Zhu; Meijuan Huang; Youling Gong
Journal:  Radiat Oncol       Date:  2012-06-19       Impact factor: 3.481

View more
  19 in total

1.  Genetic polymorphisms of ATG5 predict survival and recurrence in patients with early-stage esophageal squamous cell carcinoma.

Authors:  Pei-Wen Yang; Min-Shu Hsieh; Ya-Han Chang; Pei-Ming Huang; Jang-Ming Lee
Journal:  Oncotarget       Date:  2017-09-08

2.  Downregulation of MiR-31 stimulates expression of LATS2 via the hippo pathway and promotes epithelial-mesenchymal transition in esophageal squamous cell carcinoma.

Authors:  Yanping Gao; Jun Yi; Kai Zhang; Fan Bai; Bing Feng; Rui Wang; Xiaoyuan Chu; Longbang Chen; Haizhu Song
Journal:  J Exp Clin Cancer Res       Date:  2017-11-16

3.  N6-methyladenosine demethylase ALKBH5 suppresses malignancy of esophageal cancer by regulating microRNA biogenesis and RAI1 expression.

Authors:  Pengxiang Chen; Song Li; Ke Zhang; Renchang Zhao; Jianfeng Cui; Wei Zhou; Yuchen Liu; Lin Zhang; Yufeng Cheng
Journal:  Oncogene       Date:  2021-07-26       Impact factor: 9.867

4.  Plasma Circulating Tumor DNA Sequencing Predicts Minimal Residual Disease in Resectable Esophageal Squamous Cell Carcinoma.

Authors:  Tao Liu; Qianqian Yao; Hai Jin
Journal:  Front Oncol       Date:  2021-05-20       Impact factor: 6.244

5.  Laparoscopic management of isolated metachronous adrenal metastases in a patient with esophageal cancer: a case report.

Authors:  Tarun Jindal; Ankush Sarwal; Pravin Pawar; M Dhanalakshmi; Neeraj Subedi
Journal:  J Med Case Rep       Date:  2021-07-12

6.  Prognosis and Treatment After Diagnosis of Recurrent Esophageal Carcinoma Following Esophagectomy with Curative Intent.

Authors:  K Parry; E Visser; P S N van Rossum; N Haj Mohammad; J P Ruurda; R van Hillegersberg
Journal:  Ann Surg Oncol       Date:  2015-09-03       Impact factor: 5.344

7.  Visible-absorption spectroscopy as a biomarker to predict treatment response and prognosis of surgically resected esophageal cancer.

Authors:  Pei-Wen Yang; I-Jen Hsu; Chun-Wei Chang; Yu-Chia Wang; Ching-Yueh Hsieh; Kuan-Hui Shih; Li-Fan Wong; Nai-Yu Shih; Min-Shu Hsieh; Max Ti-Kuang Hou; Jang-Ming Lee
Journal:  Sci Rep       Date:  2016-09-14       Impact factor: 4.379

8.  Analysis of risk factors for post-operative complications and prognostic predictors of disease recurrence following definitive treatment of patients with esophageal cancer from two medical centers in Northwest China.

Authors:  Jichang Wang; Boxiang Zhang; Jinying Meng; Guodong Xiao; Xiang Li; Gang Li; Sida Qin; Ning Du; Jia Zhang; Jing Zhang; Chongwen Xu; Shou-Ching Tang; Rui Liang; Hong Ren; Xin Sun
Journal:  Exp Ther Med       Date:  2017-07-25       Impact factor: 2.447

9.  Impact of anesthetic agents on overall and recurrence-free survival in patients undergoing esophageal cancer surgery: A retrospective observational study.

Authors:  In-Jung Jun; Jun-Young Jo; Jong-Il Kim; Ji-Hyun Chin; Wook-Jong Kim; Hyeong Ryul Kim; Eun-Ho Lee; In-Cheol Choi
Journal:  Sci Rep       Date:  2017-10-25       Impact factor: 4.379

10.  Hepatectomy promotes recurrence of liver cancer by enhancing IL-11-STAT3 signaling.

Authors:  Dongyao Wang; Xiaohu Zheng; Binqing Fu; Zhigang Nian; Yeben Qian; Rui Sun; Zhigang Tian; Haiming Wei
Journal:  EBioMedicine       Date:  2019-07-30       Impact factor: 8.143

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.